Table 1 Patient characteristics (n = 230)
Variables | Value |
|---|---|
Age (year) | 62.7 ± 9.7 |
Male | 111 (48.3%) |
Smoking (yes) | 69 (30.0%) |
Hypertension (yes) | 87 (37.8%) |
Diabetes mellitus (yes) | 27 (11.7%) |
Lesion location | |
Right upper lobe | 66 (28.7%) |
Right middle lobe | 27 (7.4%) |
Right lower lobe | 52 (22.6%) |
Left upper lobe | 59 (25.7%) |
Left lower lobe | 36 (15.7%) |
T stage | |
T1a | 19 (8.3%) |
T1b | 111 (48.3%) |
T1c | 66 (28.7%) |
T2a | 34 (14.8%) |
IASLC grading | |
Grade 1 | 29 (12.6%) |
Grade 2 | 177 (77.0%) |
Grade 3 | 24 (10.4%) |
Imaging sign | |
Lobulation (yes) | 95 (41.3%) |
Spiculation (yes) | 55 (23.9%) |
Cavity (yes) | 8 (3.5%) |
Air bronchogram (yes) | 22 (9.6%) |
Vessel convergence (yes) | 10 (4.3%) |
Pleural indentation (yes) | 90 (39.1%) |
Tumor size (mm) | 20.9 ± 8.0 |
CEA (μg/L) | 4.6 ± 7.0 |
CYFRA21-1 (ng/ml) | 2.6 ± 1.3 |
SCCA (μg/L) | 0.9 ± 0.6 |
NSE (ng/ml) | 12.8 ± 3.4 |
ProGRP (ng/L) | 49.6 ± 25.0 |
Albumin (g/L) | 40.3 ± 4.4 |
White blood cell (X109/L) | 5.78 ± 1.73 |
Neutrophil-to-lymphocyte ratio | 2.06 ± 1.10 |
Platelet-to-lymphocyte ratio | 0.27 ± 0.11 |
SUVmax | 4.7 ± 3.0 |
SUVmean | 2.8 ± 1.8 |
MTV (cm3) | 6.2 ± 5.9 |
TLG | 18.7 ± 24.9 |